Table 1.
Demographic | PD patients (n = 24) | HCs (n = 26) | Analyses |
---|---|---|---|
Age | 63.42 ± 10.82 | 64.88 ± 8.06 | P = 0.5918, Two sample t-test |
Sex (M:F) | 22:2 | 17:9 | P = 0.06, Chi squared test |
Handedness (R:L) | 20:4 | 24:2 | P = 0.3293, Chi squared test |
H and Y Stage | 1.75 ± 0.47 | NA | - |
UPDRS score | 25.04 ± 11.01 | NA | - |
MOCA | 26.54 ± 2.01 | NA | - |
LEDD (mg) | 537.64 ± 340.69 | NA | - |
MOCA The Montreal Cognitive Assessment, H and Y Hoehn and Yahr stage, UPDRS Unified Parkinson’s Disease Rating Scale (pre-intervention and off medication), LEDD Levodopa Equivalent Daily Dose, M male, F female, R right, L left